In addition, it was recently demonstrated that in the most common malignant pediatric brain tumor, medulloblastoma, CSF1R has an anti-tumoral affect, and targeting it resulted in accelerated tumor growth [61]. This evidence concerns the gene CSF1R and neoplasm.